4D Molecular Therapeutics, Inc. (FDMT) insider trading.
In Q3 2026, insiders at 4D Molecular Therapeutics, Inc. reported 20 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $3.2M.
- Transactions
- 20
- Purchases (P)
- 0
- Sales (S)
- 13
- Net shares, P minus S
- -237,054
- Insiders
- 2
- Last filed
- 2026-09-22
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Bizily Scott | Officer · Chief Legal Officer | 11 | 0 | 5 |
| Kirn David | Director, Officer · See Remarks | 9 | 0 | 8 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Bizily Scott | M (A) | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-09-16 | Bizily Scott | S (D) | 1,635 | $13.65 | 8,617 | Form 4 |
| 2026-09-14 | Kirn David | S (D) | 58,333 | $13.9 | 767,486 | Form 4 |
| 2026-09-01 | Bizily Scott | S (D) | 584 | $14 | 8,617 | Form 4 |
| 2026-09-01 | Bizily Scott | M (A) | 584 | $6.49 | 9,201 | Form 4 |
| 2026-08-19 | Kirn David | S (D) | 43,149 | $15.36 | 851,746 | Form 4 |
| 2026-08-19 | Kirn David | S (D) | 25,927 | $16.42 | 825,819 | Form 4 |
| 2026-08-19 | Kirn David | M (A) | 50,000 | $4.14 | 894,895 | Form 4 |
| 2026-08-17 | Bizily Scott | S (D) | 1,635 | $12.2 | 8,617 | Form 4 |
| 2026-08-17 | Bizily Scott | M (A) | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-08-13 | Bizily Scott | M (A) | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-08-13 | Bizily Scott | S (D) | 1,635 | $12 | 8,617 | Form 4 |
| 2026-08-04 | Kirn David | S (D) | 26,842 | $10.23 | 844,895 | Form 4 |
| 2026-08-03 | Kirn David | S (D) | 12,415 | $10.05 | 871,737 | Form 4 |
| 2026-07-10 | Kirn David | S (D) | 15,283 | $12.01 | 884,594 | Form 4 |
| 2026-07-10 | Kirn David | S (D) | 442 | $12.84 | 884,152 | Form 4 |
| 2026-07-09 | Kirn David | S (D) | 42,608 | $12.87 | 899,877 | Form 4 |
| 2026-06-30 | Bizily Scott | M (A) | 5,752 | $6.49 | 15,183 | Form 4 |
| 2026-06-30 | Bizily Scott | M (A) | 814 | $4.14 | 9,431 | Form 4 |
| 2026-06-30 | Bizily Scott | S (D) | 6,566 | $14 | 8,617 | Form 4 |
Transaction codes in this quarter
Get FDMT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1650648&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · FDMT company page · 4D Molecular Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling 4D Molecular Therapeutics, Inc. (FDMT)?
In Q3 2026, insiders at 4D Molecular Therapeutics, Inc. reported 20 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $3.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these 4D Molecular Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/fdmt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.